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We have previously shown that targeted overexpression of the endogenous angiogenesis inhibitor thrombos-
pondin-1 (TSP-1) in the epidermis prevented chronic ultraviolet B (UVB)-induced angiogenesis and cutaneous
photodamage in mice, suggesting that angiogenesis plays a critical role in the mediation of UVB effects on the skin.
Nevertheless, the molecular regulation of angiogenesis factors and inhibitors by acute UVB irradiation still remains
to be elucidated. We performed quantitative analyses of cutaneous vascularity and of vascular endothelial growth
factor (VEGF) and TSP-1 expression after acute UVB irradiation of mouse skin. Skin vascularity in the upper dermis
was greatly increased until day 8 after a single dose of UVB irradiation (200 mJ per cm2) and associated with
upregulation of VEGF mRNA expression, with downregulation of TSP-1 mRNA, and with protein expression in the
hyperplastic epidermis. After 13 days, skin vascularity was normalized with downregulation of VEGF mRNA
expression and upregulation of TSP-1 mRNA expression to the levels observed in non-UVB-irradiated skin. In
contrast, the angiogenic UVB response was prolonged in TSP-1-deﬁcient mice. We found a pronounced induction
of the TSP-1 receptor CD36 in CD31-positive vessels on day 8 after UVB irradiation, associated with vascular
endothelial cell apoptosis. These results demonstrate that acute UVB irradiation leads to a shift toward a
proangiogenic environment and they suggest that the balance between VEGF and TSP-1 plays a critical role in the
control of angiogenesis and vascular regression induced by acute UVB irradiation.
Key words: angiogenesis/vascular regression/thrombospondin (TSP-1)/acute UVB irradiation
J Invest Dermatol 122:201 –208, 2004
Chronic sun exposure of human skin results in wrinkle
formation, elastosis, and degradation of matrix macromo-
lecules (Kligman, 1989; Leyden et al, 1989) and leads to an
enhanced risk for the development of epithelial skin cancers
(Kripke, 1994). Skin alterations observed after a single
exposure to ultraviolet B (UVB) irradiation (290- to 320-nm
wavelength) include erythema (Cox et al, 1992; Kripke,
1994), vascular hyperpermeability, dilation of dermal blood
vessels, and epidermal hyperplasia (Pearse et al, 1987;
Berton et al, 1997). The pronounced vascular changes
observed after acute UVB irradiation suggest that the cuta-
neous vasculature plays an important role in the mediation
of acute photodamage. Several angiogenic factors, includ-
ing vascular endothelial growth factor (VEGF), basic fibro-
blast growth factor, and interleukin-8 (Bielenberg et al, 1998;
Kramer et al, 1993; Strickland et al, 1997), have been found
to be upregulated after UVB irradiation of the skin, whereas
a decreased expression of interferon-b, a cytokine with
antiangiogenic activity, has been reported (Bielenberg et al,
1998). Nevertheless, the regulation of endogenous inhibitors
of angiogenesis by acute UVB irradiation has remained
unknown.
Angiogenesis, the formation of new blood vessels from
existing vessels, involves increased microvascular perme-
ability, degradation of extracellular matrix molecules, and
proliferation and migration of endothelial cells, leading to
the formation of new capillaries (Dvorak et al, 1995). In
normal skin, angiogenesis is restricted to the perifollicular
vasculature during the growth phase of the hair follicle (Yano
et al, 2001). Nevertheless, the skin can initiate a rapid
angiogenic response during wound healing and inflamma-
tion. We have previously identified VEGF, released by
epidermal keratinocytes, as a major skin angiogenesis
factor (Detmar et al, 1995). VEGF expression is upregulated
in the hyperplastic epidermis of psoriasis (Detmar et al,
1994), in healing wounds (Brown et al, 1992), and in other
skin diseases characterized by enhanced angiogenesis
(Brown et al, 1995a, b). Moreover, targeted overexpression
of VEGF in the epidermis of transgenic mice resulted in
enhanced skin vascularization with increased numbers of
tortuous and hyperpermeable blood vessels (Detmar and
Brown, 1998). Pronounced upregulation of VEGF mRNA
expression was also detected in murine skin after chronic
UVB irradiation (Yano et al, 2002).
Abbreviations: BrdU, bromodeoxyuridine; TSP-1, throm-
bospondin-1; UVB, ultraviolet B.
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Thrombospondin-1 (TSP-1) is a 450-kDa matricellular
protein that inhibits proliferation and migration of endothelial
cells in vivo and potently diminishes squamous cell
carcinoma growth and angiogenesis in vivo (Tolsma et al,
1993; Bleuel et al, 1999; Streit et al, 1999). TSP-1 mediates
inhibition of proliferation and migration of endothelial cells
by specific interaction of distinct sequences within its type I
repeats with the CD36 receptor on endothelial cells
(Jimenez et al, 2000). In human skin, TSP-1 mRNA is
produced by epidermal keratinocytes, contributing to the
normal antiangiogenic barrier that separates the avascular
epidermis from the vascularized dermis (Detmar, 2000). We
have previously reported that mice with skin-specific
overexpression of TSP-1 showed diminished skin damage
and angiogenesis after chronic UVB irradiation (Yano et al,
2002), suggesting that inhibition of angiogenesis might
prevent UVB-mediated photodamage. The regulation of
TSP-1 expression by UVB, however, has remained unclear.
Here, we report that enhanced cutaneous vascularity
after UVB irradiation is associated with an angiogenic
switch. UVB irradiation induced upregulation of VEGF
mRNA expression and downregulation of TSP-1 mRNA
expression in the epidermis, resulting in a shift toward a
proangiogenic environment. Skin vascularity was reduced
to normal levels at approximately 10 d after UVB irradiation,
associated with endothelial cell apoptosis, upregulation of
epidermal TSP-1 expression, and induction of the TSP-1
receptor CD36 on blood vessels. Moreover, the angiogenic
UVB response was prolonged in TSP-1-deficient mice.
These results suggest that the balance between VEGF and
TSP-1 expression plays a critical role in the mediation of
angiogenesis and vascular regression in UVB-irradiated
skin.
Results
A single dose of UVB irradiation induces epidermal
hyperplasia and dermal angiogenesis To investigate the
effects of acute UVB irradiation on angiogenesis in the skin,
we exposed 30 female HR-1 hairless mice to a single dose
of UVB irradiation (200 mJ per cm2). Histologic analysis
showed thickening of the epidermis (Fig 1a–e) and the
dermis (data not shown) in UVB-treated mice, associated
with recruitment of inflammatory cells to the upper dermis
(data not shown). Immunohistochemistry for the endothelial
junction molecule CD31 revealed a progressive increase in
the number of enlarged blood vessels in UVB irradiated skin
until day 8 (Fig 1f–i ). Skin vascularity returned to levels
before irradiation on day 13 (Fig 1j ) after UVB irradiation.
Computer-assisted morphometric analysis of CD31-stained
cutaneous vessels revealed a significant increase in
vascular density on day 4 (þ23%; po0.01) and day 8
(þ30%; po0.001) after UVB irradiation, compared with
nonirradiated skin (Fig 1q). Moreover, the average vessel
size was significantly increased on day 2 (þ 21%; po0.05),
day 4 (þ 115%; po0.001), and day 8 (149%; po0.001)
after UVB irradiation (Fig 1p). Accordingly, the cutaneous
area covered by blood vessels was increased on day 2
(þ23%; po0.001), day 4 (þ101%; po0.001), and day 8
Figure 1
A single dose of UVB irradiation induces epider-
mal hyperplasia and dermal angiogenesis. Histo-
logic analysis revealed pronounced epidermal
hyperplasia (a–d) on days 2, 4, and 8 after UVB
irradiation, followed by normalization on day 13 (e).
CD31 immunostains (f–j) and CD31 and BrdU
double-immunofluorescence stains (k–o) revealed
increased vascularization with more numerous and
enlarged blood vessels (h,i), accompanied by pro-
liferation of endothelial cells (m,n) in acute UVB-
treated mice, most prominently in the upper dermis,
compared with UV (–) control mice (f,k). Computer-
assisted morphometric analysis of CD31-stained
sections demonstrated a significant increase of the
average vessel size (p), vessel density (q), and the
relative skin area covered by blood vessels (r) in
UVB-irradiated mice, compared with nonirradiated
control mice. Data are expressed as mean
(n¼5)  SD of three independent experiments.
po0.05, po0.01, po0.001 (increase over
non-UVB-irradiated skin). Bars, 110 mm.
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(þ195%; po0.001) (Fig 1r ), compared with nonirradiated
skin. Importantly, on day 13, all vascular parameters
examined were comparable to the levels of non-UVB-
irradiated skin (Fig 1p,q,r ).
Double immunofluorescence stains for CD31 and BrdU
revealed increased proliferation of epidermal keratinocytes
beginning on day 2 (Fig 1L) after UVB irradiation, resulting in
prominent epidermal hyperplasia from day 4 (Fig 1c,m) to day
8 (Fig 1d,n). Proliferation of endothelial cells was detected on
day 4 (Fig 1m) and, more prominently, on day 8 (Fig 1n). No
proliferating endothelial cells were detected in non-UVB-
irradiated skin (Fig 1k) on day 13 after UVB irradiation (Fig 1o).
Induction of VEGF and repression of TSP-1 mRNA
expression after acute UVB irradiation We next exam-
ined the effects of acute UVB irradiation on epidermal VEGF
and TSP-1 mRNA expression levels. Using quantitative real-
time RT-PCR analysis of total RNA isolated from the
epidermis of mouse skin, we found that VEGF mRNA
expression levels were significantly upregulated on day 2
(þ289%; po0.05), day 4 (þ420%; po0.01), and day 6
(þ298%; po0.05) after UVB treatment, compared with
nonirradiated skin. This was followed by gradual down-
regulation on days 8 and 13 to the levels observed in normal
skin (Fig 2a). All three major VEGF isoforms, VEGF 120,
VEGF 164, and VEGF188, were comparably upregulated
(data not shown). In contrast, TSP-1 mRNA expression was
potently downregulated on day 2 (–92%; po0.01), day 4
(– 70%; po0.05), and day 6 (–49%; n.s.) after UVB
treatment, followed by normalization of expression levels
on days 8 and 13 to the levels observed in nonirradiated
skin (Fig 2a). Importantly, the ratio of VEGF to TSP-1
expression levels was 0.3 in normal skin in accordance with
the normal vascular quiescence, whereas the VEGF-to-
TSP-1 ratio was dramatically increased on days 2 and 4
after UVB irradiation (Fig 2b), indicative of a proangiogenic
switch induced by UVB irradiation.
Immunohistochemical stains for VEGF and TSP-1 con-
firmed these findings. Whereas no or little VEGF was
detected in normal skin (Fig 3a), its expression was strongly
increased in the epidermis and in endothelial cells from day
2 to day 8 (Fig 3b–d ) after UVB irradiation. VEGF expression
on day 13 (Fig 3e) was comparable to the levels observed in
normal skin. In contrast, high levels of TSP-1 expression
were observed in the epidermis and in endothelial cells in
normal skin (Fig 3f ), with pronounced downregulation 2 and
4 d after UVB irradiation (Fig 3g,h). Importantly, strong TSP-
1 expression was again detected on days 8 and 13 (Fig 3I, j )
after UVB irradiation, comparable with the levels in normal
skin (Fig 3f ). In situ hybridization for TSP-1 confirmed the
results seen by immunostains. TSP-1 mRNA was constitu-
tively and highly expressed throughout the normal epider-
mis, predominantly within the suprabasal keratinocyte layer
(Fig 3k). In addition, moderate TSP-1 mRNA expression was
detected in endothelial cells and in some fibroblasts in
normal skin (Fig 3k). In contrast, a pronounced down-
regulation of TSP-1 mRNA expression was detected on day
2 (Fig 3L) and day 4 (Fig 3m) after UVB irradiation. In
accordance with the immunohistochemical data, TSP-1
mRNA expression returned to normal levels on day 8 (Fig
3n) and day 13 (Fig 3o) after UVB irradiation.
Induction of endothelial CD36 expression and endothe-
lial cell apoptosis on day 8 after UVB irradiation CD36 is
an endothelial cell receptor for TSP-1 that has been
implicated in the induction of endothelial cell apoptosis
(Jimenez et al, 2000). Double immunofluorescence stains
for CD31 and CD36 revealed induction of CD36 expression
in vascular endothelial cells in the upper dermis on day 8
after UVB irradiation (Fig 4b), compared with absent or low-
level expression in non-UVB-irradiated skin (Fig 4a). Double
immunofluorescence stains for CD31 and TUNEL revealed
several apoptotic endothelial cells in the upper dermis 8 d
after UVB irradiation (Fig 4d), whereas no apoptotic
endothelial cells were detected in normal skin (Fig 4c).
Prolonged angiogenic UVB response in TSP-1-deﬁcient
mice To investigate whether the observed upregulation of
TSP-1 expression was necessary to mediate the vascular
regression during the late phase of the UVB response, we
next subjected TSP-1 deficient mice (TSP-1–/–) and their
wild-type controls to the same UVB irradiation regimen and
Figure2
Upregulation of cutaneous VEGF mRNA expression and down-
regulation of TSP-1 mRNA expression after acute UVB irradiation.
Real-time RT-PCR analysis showed pronounced upregulation of
epidermal VEGF mRNA expression on days 2, 4, and 6 after UVB
irradiation, compared with non-UVB-irradiated skin. In contrast, TSP-1
mRNA expression was downregulated in the epidermis on days 2, 4,
and 6 after UVB irradiation, compared with non-UVB-irradiated skin (a).
The relative ratio of VEGF mRNA expression to TSP-1 mRNA
expression was temporally correlated with the extent of dermal
angiogenesis after UVB irradiation (b). Data are expressed as
means  SD (n¼5) of three independent experiments. po0.01,
po0.05 (increase over non-UVB-irradiated skin).
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determined skin vascularity on day 0 (before UVB irradia-
tion) and on day 13. Whereas no major differences of
cutaneous vascularity were detected in the nonirradiated
skin of both genotypes (Fig 5a,b), enhanced vascularity—as
visualized by CD31 immunofluorescence stains—was still
detected in the skin of TSP-1-deficient mice on day 13 after
UVB irradiation (Fig 5d). In contrast, the cutaneous
vascularity had largely returned to baseline levels in wild-
type mice at this time point (Fig 5c,e).
Discussion
Acute photodamage of the skin is characterized by
epidermal hyperplasia and by erythema formation. Pre-
viously, endothelial cell proliferation has been found after
acute UVB irradiation of the skin (Bielenberg et al, 1998).
Nevertheless, the distinct regulation of the major skin
angiogenesis factor VEGF and the endogenous angiogen-
esis inhibitor TSP-1 by UVB have remained unclear. Our
results identify the induction of a proangiogenic switch by
acute UVB irradiation. TSP-1 expression dominated over
VEGF expression in normal skin, in accordance with the
normal quiescence of the cutaneous vasculature. In con-
trast, acute UVB irradiation resulted in pronounced upregu-
lation of VEGF and in downregulation of TSP-1 expression,
leading to a shift toward a proangiogenic environment.
Normalization of VEGF and TSP-1 expression and induction
of the endothelial TSP-1 receptor CD36 on day 8 after UVB
irradiation resulted in apoptosis-driven vascular regression.
Figure3
Immunohistochemistry for VEGF and TSP-1 and in
situ hybridization for TSP-1 Immunostains for VEGF
and TSP-1 demonstrated a pronounced increase of
VEGF expression in the epidermis on day 2 (b), day 4
(c), and day 8 (d) after UVB irradiation, compared with
non-UVB-irradiated skin (a), followed by downregula-
tion on day 13 (e) to the levels of non-UVB-treated
skin. In contrast, TSP-1 expression was reduced in
the epidermis on day 2 (g) and day 4 (h) after acute
UVB irradiation, followed by a gradual increase on
day 8 (i) and day 13 (j) to the levels observed in non-
UVB-irradiated skin (f). In situ hybridization for TSP-1
revealed a downregulation of TSP-1 on day 2 (l) and
day 4 (m) after UVB irradiation, compared with normal
skin (k), followed by an increase on day 8 (n) and day
13 (o) to normal levels. Bars, 55 mm.
Figure4
Enhanced of endothelial CD36 expression and
endothelial cell apoptosis on day 8 after UVB
irradiation. Double immunofluorescence stains for
CD31 (green) and CD36 (red) revealed a marked
induction of CD36 expression on cutaneous endothe-
lial cells (arrows) on day 8 (b) after acute UVB
irradiation, compared with non-UVB-treated skin (a).
Differential immunofluorescence stains for CD31 (red)
and for apoptotic nuclei (green) revealed increased
numbers of apoptotic endothelial cells (arrows) on
day 8 (d) after acute UVB irradiation, whereas no
endothelial cell apoptosis was detected in non-UVB-
treated skin (c). Bars, 110 mm (a,b) and 55 mm (c,d).
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Quantitative morphometric analysis of tissue sections
stained for the endothelial junction molecules CD31 (Dejana
et al, 1995) revealed a marked induction of skin angiogen-
esis after acute UVB irradiation, with a significant increase
of both vessel density and vessel size that was accom-
panied by increased proliferation of endothelial cells. These
findings were comparable to the angiogenic changes that
occur in chronically photodamaged skin (Yano et al, 2002)
and in cutaneous wound healing where both sprouting from
existing blood vessels and vessel enlargement contribute to
the formation of a vessel-rich granulation tissue (Streit et al,
2000). In contrast, chronic inflammatory skin diseases such
as psoriasis predominantly show vascular remodeling with
elongation and enlargement of cutaneous microvessels
without the formation of new blood vessels (Braverman and
Keh-Yen, 1986; Detmar et al, 1994). Our findings indicate
that acute UVB irradiation of the skin results in a tissue-
repair-like reaction and they suggest that angiogenesis
might play a important role in the mediation of acute UVB-
induced skin damage. It is of interest that we detected a
significant increase in the average vessel size, but not in
vessel density 2 d after acute UVB irradiation, whereas both
vessel size and density were increased from day 4 to day 8.
These findings indicate a biphasic regulation of the vascular
response to acute UVB irradiation, with an initial phase of
vasodilation, followed by a second phase of sprouting
angiogenesis and endothelial cell proliferation. A previous
study found prolonged angiogenesis over at least 4 wk after
a single dose of UVB irradiation of ear skin (Bielenberg et al,
1998), whereas in our study, angiogenic vessels regressed
within 2 wk after UVB irradiation of the dorsal body skin.
This difference in the time course of the vascular response
is likely due to different UVB sensitivity of dorsal skin and of
ear skin that is more richly vascularized.
VEGF is a major keratinocyte-derived skin angiogenesis
factor (Detmar et al, 1995). Its expression is upregulated by
the hyperplasic epidermis in chronic UVB-irradiated skin
(Yano et al, 2002), in psoriatic lesions (Detmar et al, 1994),
and in other skin diseases associated with dermal angio-
genesis (Brown et al, 1995a; Brown et al, 1995b), as well as
in the neoepidermis of healing wounds (Brown et al, 1992;
Kishimoto et al, 2000). In general, VEGF has been found to
be upregulated in most, if not all, skin conditions that are
characterized by epidermal hyperplasia and dermal angio-
genesis. In contrast, the endogenous angiogenesis inhibitor
TSP-1 is expressed by epidermal keratinocytes in normal
skin (Wight et al, 1985) and is thought to contribute to the
quiescence of the cutaneous vasculature in normal human
skin (Detmar, 2000). We detected constitutive TSP-1 mRNA
and protein expression in the entire epidermis of normal
skin, predominantly in the upper epidermal layers. In a
previous report by Wight et al (1995), the authors found—
using an affinity-purified rabbit anti-TSP-1 antibody on
frozen sections of human skin—selective staining for TSP-1
in the basement membrane region below the epidermis,
likely representing secreted TSP-1 that was bound to the
matrix. These findings suggest that the antibody used in
that study only recognized the secreted TSP-1 protein or a
protein fragment of TSP-1. In contrast, in our study we have
used a monoclonal rat anti-TSP-1 antibody that recognizes
the 450-kDa TSP-1 protein also within the cytoplasm of
basal and suprabasal keratinocytes and other cells.
Importantly, the in situ hybridization results confirmed that
both basal and suprabasal keratinocytes produced TSP-1,
as evidenced by strong mRNA expression by these cells.
Taken together, cellular production of TSP-1 by epidermal
keratinocytes, leading to secretion and deposition in the
dermal matrix and the basement membrane zone, likely
contribute to the antiangiogenic barrier that prevents vessel
ingrowth into the epidermis.
We have previously reported that transgenic mice with
selective overexpression of TSP-1 in basal epidermal
keratinocytes and in outer root sheath follicular keratino-
cytes showed reduced dermal damage, wrinkle formation,
and angiogenesis after chronic UVB irradiation (Yano et al,
2002). Based on these findings, we hypothesized that the
Figure 5
Prolonged angiogenic UVB response in TSP-1-deficient mice. TSP-1 deficient mice (TSP-1–-/–) and their wild-type controls were subjected to a
single dose of UVB irradiation (200 mJ per cm2). Whereas no major differences of cutaneous vascularity were detected in the nonirradiated skin of
both genotypes (a,b), enhanced vascularity—as visualized by CD31 immunofluorescence stains (red)—was still detected in the skin of TSP-1
deficient mice on day 13 after UVB irradiation (d). In contrast, the cutaneous vascularity had largely returned to baseline levels in wild-type mice at
this time point (c.e). Hoechst nuclear counterstain (blue). Data in e are expressed as means (n¼5)  SEM. po0.05.
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balance of VEGF and TSP-1 expression might play a critical
role in the shift from vascular quiescent to a proangiogenic
environment. This study confirmed a predominant expres-
sion of TSP-1 but low levels of VEGF in normal skin.
Importantly, UVB irradiation led to an upregulation of VEGF
and downregulation of TSP-1 in the epidermis during the
first 6 d after UVB irradiation, suggesting that the increased
VEGF-to-TSP-1 ratio contributed to the molecular induction
of the angiogenic switch. In situ hybridization for TSP-1
confirmed the results of quantitative PCR that pronounced
downregulation of TSP-1 mRNA expression was detected
on days 2, 4, and 6 after acute UVB irradiation, followed by
upregulation of expression on day 8 and day 13 to the levels
found in non-UVB-treated skin. These findings are in accor-
dance with previous reports that acute or chronic UVB
irradiation induced VEGF expression by human epidermal
keratinocytes in vitro (Brauchle et al, 1996; Mildner et al,
1999; Blaudschun et al, 2002) and by murine keratinocytes
in vivo (Bielenberg et al, 1998; Yano et al, 2002).
Interestingly, upregulation of another angiogenic factor,
basic fibroblast growth factor, and downregulation of
interferon-b, a cytokine with antiangiogenic activity, has
been previously found after a single dose of UVB irradiation
of mouse ear skin (Bielenberg et al, 1998), suggesting that
additional factors contribute to the angiogenic UVB re-
sponse. Moreover, a similar switch in the expression levels
of VEGF and TSP-1 has recently been observed during the
progressive phase of multistep epithelial carcinogenesis
that is associated with pronounced tumor angiogenesis
(Hawighorst et al, 2002). It will be of interest to investigate,
in future studies, the biologic importance of other endo-
genous angiogenesis inhibitors for the cutaneous UVB
response. Preliminary results indicate that the related
molecule thrombospondin-2 is also downregulated after
UVB irradiation of mouse skin, although less potently than
TSP-1 (data not shown).
We observed that the shift from the proangiogenic
environment to vascular quiescence at 13 d after UVB
irradiation was associated with upregulation of TSP-1 and do-
wnregulation of VEGF expression to the levels of non-UVB-
treated skin. These results further corroborate the close
correlation between TSP-1 and VEGF expression levels and
cutaneous vascularization, and they implicate TSP-1 as a
key factor in the mediation of vascular regression during the
late stages of the cutaneous UVB response. Indeed, we
found that the angiogenic UVB response was prolonged in
mice deficient for TSP-1, demonstrating that TSP-1
upregulation is necessary for the timely vascular regression
during the late phase of the UVB response.
It has been recently reported that TSP-1 mediates
inhibition of angiogenesis by specific interactions of distinct
sequences with the type I repeats with the CD36 receptor
on the endothelial cells, resulting in enhanced endothelial
cell apoptosis rates (Jimenez et al, 2000). We found
concomitant induction of endothelial CD36 expression and
endothelial apoptosis in cutaneous vessels 8 d after acute
UVB irradiation, temporally associated with upregulation of
TSP-1 expression to the levels detected in normal skin.
These results suggest that the vascular regression observed
during the late stages of the UVB response was, at least
partially, mediated via the TSP-1–CD36 signal transduction
pathway. Future studies in CD36-deficient mice will likely
provide important information regarding the relative con-
tribution of the CD36 to the angiogenic activity of TSP-1.
Taken together, our findings suggest that changes in the
normal balance between VEGF and TSP-1 expression in the
skin play an important role in the mediation of UVB-induced
cutaneous photodamage with potential implications for the
development of novel strategies to prevent UVB-induced
skin-aging.
Materials and Methods
UVB irradiation and skin samples A total of 30 female albino
hairless HOS:HR-1 mice (Hoshino Laboratory Animal Co., Ltd,
Japan) were exposed to a single dose of UVB irradiation (200 mJ
per cm2) at 8 wk of age using 10 Toshiba FL-20 SE fluorescent
lamps that deliver energy in the UVB (280–340 nm) wavelength
range, with a maximum energy at a wavelength of 305 nm
(Naganumaa et al, 2001). During irradiation, the height of the lamps
was adjusted to deliver 0.3 mW per cm2 at the dorsal skin surface
of the anesthetized mice. The mice were euthanized on days 0, 2,
4, 6 (only for PCR analysis), 8, and 13 (n¼ 5 per each time point)
after UVB irradiation. In an additional experiment, TSP-1-deficient
mice (Lawler et al, 1998) and wild-type FVB control mice were
subjected to a single dose of UVB as described above (200 mJ per
cm2) and were euthanized on days 0 and 13 (n¼ 5 per group).
Dorsal skin samples were obtained and were snap-frozen, fixed in
10% formalin, and fixed in cold acetone to process for histologic
analysis as described (Sato et al, 1986). All animal studies were
approved by the Shiseido Life Science Research Center Sub-
committee on Research Animal Care and the Massachusetts
General Hospital Subcommittee on Research Animal Care.
Immunohistochemistry for CD31 and computer-assisted mor-
phometric analysis of cutaneous blood vessels Immunohisto-
chemical stainings were performed on 5-mm frozen sections as
described (Yano et al, 2002), using a monoclonal rat anti-mouse
CD31 antibody (PharMingen, San Diego, CA). Representative
sections were obtained from five UVB-irradiated mice and from
five age-matched, non-UVB-irradiated control mice for each time
point and were analyzed using an Olympus Vanox AHBT-3
microscope (Olympus, Japan). Images were captured with a Spot
digital camera (Diagnostic Instruments, Sterling Heights, MI), and
morphometric analyses were performed using the IP-LAB software
(Scanalytics Inc, Fairfax, VA) as described (Yano et al, 2002). Three
different fields of each section were examined at 60 magnifica-
tion, and the number of vessels per square millimeter, the average
vessel size, and the relative area occupied by blood vessels were
determined in the dermis, in an area within 100 mm distance from
the epidermal–dermal junction. The two-sided unpaired Student’s t
test was used to analyze differences in microvessel density and
vascular size. In addition, paraffin sections were obtained from the
skin of the same mice, and routine hematoxylin-eosin stains were
performed as described (Prophet et al, 1992).
Immunohistochemistry Immunohistochemical stainings for VEGF
and TSP-1 were performed on 5-mm AMeX-fixed sections using a
polyclonal rabbit anti-VEGF antibody (Ab-1; Neomarkers, Fremont,
CA) or a monoclonal rat antihuman TSP-1 antibody (Immunotech,
France). Double immunofluorescence stains for CD31 and CD36
were performed using a rat monoclonal antimouse CD31 (PharMin-
gen) and a rabbit polyclonal anti-human CD36 antibody (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA). Anti-rat IgG antibodies
conjugated with FITC and anti-mouse IgG antibodies conjugated
with Texas red (Jackson ImmunoResearch Laboratories, West
Grove, PA) were used as secondary antibodies. Images were
captured with a Spot digital camera.
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In situ hybridization for TSP-1 In situ hybridization was per-
formed on 5-mm 10% formalin-fixed skin sections using a signal
amplification method based on the deposition of biotinylated
tyramine as previously described (Kerstens et al, 1995). Mouse
TSP-1 cDNA (nucleotides 1060–1360; GenBank Accession No.
NM_011580) was amplified by reverse transcription–PCR. Digox-
igenin-labeled antisense and sense RNA probes were prepared by
in vitro transcription with T7 RNA polymerase, using mouse TSP-1
cDNA as a template.
Gene speciﬁc RT-PCR analysis and real-time RT-PCR Total
RNA was isolated from the dorsal skin of mice using Isogen
(Nippon Gene, Japan), digested with DNase I (Qiagen, Germany),
and reverse-transcribed using the Superscript first-strand synth-
esis system (Gibco BRL). VEGF, TSP-1, and G3PDH genes were
amplified using Platinum Taq DNA polymerase for 30 cycles at
581C. The PCR products were fractionated by gel electrophoresis.
To quantify the gene expression, primers and probes for VEGF,
TSP-1, and G3PDH were designed with Primer-Express software
(Applied Biosystems) as follows: VEGF forward, 50-CAACATCAC-
CATGCAGAT-30; VEGF reverse, 50-TCACCGCCTTGGCTTGTCAC-
30; VEGF detection probe, 50-FAM-AGAAAGCATTTGTTTGTCCAA-
GATCCGCAG-TAMRA-30; TSP-1 forward, 50-TCCCATCATGCCCTG-
CT-30; TSP-1 reverse, 50-ATCCTTGTGATCACACC-30; TSP-1 dete-
ction probe, 50-CACATGTGGCAATGGAATTCAGCAACG-30; G3PDH
forward, 50-GAAGGTGAAGGTCGGAGTC-30, G3PDH reverse, 50-
GAAGATGGTGATGGGATTTC-30; and G3PDH detection probe, 50-
FAM-AGGCTGAGAACGGGAAGCTTGT-TAMRA-30. The PCR mix
contained 1 mL cDNA template; 1 TaqMan buffer A; 3.5 mM
MgCl2; 200 mM each of dATP, dCTP, dGTP, and dUTP; 1.25 units
Amplitaq Gold DNA polymerase; 300 nM of each primer; and 300
nM detection probe in a total volume of 50 mL. Standard reactions
were performed using a PRISM 7700 sequence detection system
(Applied Biosystems, Foster City, CA). Identical primers were used
for both RT-PCR and Taqman PCR. All experiments were carried
out in triplicate.
Proliferation and apoptosis assays To analyze endothelial cell
proliferation, 0.2 mL of 65 mM bromodeoxyuridine (BrdU) (Sigma,
St. Louis, MO) in PBS was injected 2 h before sampling skin as
described (Yano et al, 2001). Double immunofluorescence stains
for the endothelial cell marker CD31 and for the proliferation
marker BrdU were performed on 5-mm frozen sections, using a
monoclonal rat anti-mouse CD31 antibody and a mouse anti-BrdU
monoclonal antibody (Novocastra Laboratories, Burlingame, CA).
Anti-rat IgG conjugated with FITC and anti-mouse IgG conjugated
with Texas red were used as secondary antibodies. Representative
sections were obtained from five mice for each experimental group
and were analyzed using an Olympus Vanox AHBT-3 microscope.
Digital images of CD31 (red) and BrdU (green) stains were obtained
in identical fields and were combined to reveal proliferating
endothelial cells (yellow). Apoptotic endothelial cells were detected
by double immunofluorescence, using the Fluorescence-FragEL
DNA fragmentation detection kit (Oncogene, Cambridge, MA) and
an anti-mouse CD31 antibody together with an anti-rat IgG
conjugated with Texas red as described previously (Yano et al, 2002).
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